Skip to main content
Premium Trial:

Request an Annual Quote

We're Sure It Was the 'Good Intentions' Option

TechCrunch wonders where Sergey Brin went. As you may recall, Brin's blog, called too, made a splash when it appeared in September. The second entry on the blog (right after the introductory post) announced that Brin has the LRRK2 gene for familial Parkinson's disease. As TechCrunch's Robin Wauters points out, there was never a third post. "So what I'm wondering: did Sergey Brin actually start the blog with good intentions, hoping he would find the time in his busy life to share tidbits about the personal part of it, or was this just a way for him to draw a lot of attention to his genetic mutation and - conveniently - how his wife's new startup plays a role in it?" she writes.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.